Related Experiment Video
Updated: May 30, 2025
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Application of nanomaterials in precision treatment of lung cancer
Chengcheng Zhang1, Jiang Fan1, Liang Wu1
1Department of Thoracic Surgery, Shanghai General Hospital Shanghai Jiao Tong University School of Medicine, No. 100 Haining Road, Hongkou District, Shanghai 200080, China.
Abstract:
Lung cancer remains one of the most prevalent and lethal malignancies worldwide, characterized by high mortality rates due to its aggressive nature, metastatic potential, and drug resistance. Despite advancements in conventional therapies, their efficacy is often limited by systemic toxicity, poor tumor specificity, and the emergence of resistance mechanisms. Nanomedicine has emerged as a promising approach to address these challenges, leveraging the unique physicochemical properties of nanomaterials to enhance drug delivery, reduce off-target effects, and enable combination therapies. This review provides a comprehensive overview of the applications of nanomaterials in lung cancer treatment, focusing on advancements in chemotherapy, phototherapy, and immunotherapy. Key strategies include the development of stimuli-responsive nanoparticles, active targeting mechanisms, and multifunctional platforms for co-delivery of therapeutic agents. Notable successes, such as liposomal formulations and polymeric nanoparticles, highlight the potential to overcome biological barriers and improve therapeutic outcomes. However, significant challenges remain, including limited tumor penetration, immunogenicity, scalability in manufacturing, and regulatory complexities. Addressing these limitations through innovative design, advanced manufacturing technologies, and interdisciplinary collaboration will be critical to translating nanomedicine from bench to bedside. Overall, nanomedicine represents a transformative frontier in lung cancer therapy, offering the potential to improve patient outcomes and quality of life.
Insights
Nanomedicine offers a promising strategy to improve lung cancer treatment by enhancing drug delivery and reducing side effects. Overcoming challenges like tumor penetration is key to translating these advanced nanomaterial therapies from research to clinical practice.
Area of Science:
- Oncology
- Nanotechnology
- Drug Delivery
Background:
- Lung cancer is a leading cause of cancer mortality globally, often exhibiting aggressive behavior, metastasis, and resistance to conventional treatments.
- Conventional therapies face limitations including systemic toxicity, lack of tumor specificity, and acquired drug resistance, hindering optimal patient outcomes.
Purpose of the Study:
- To provide a comprehensive review of nanomedicine applications in lung cancer therapy.
- To highlight advancements in chemotherapy, phototherapy, and immunotherapy using nanomaterials.
- To discuss strategies for overcoming biological barriers and improving therapeutic efficacy.
Main Methods:
- Review of current literature on nanomedicine in lung cancer treatment.
- Focus on stimuli-responsive nanoparticles, active targeting, and multifunctional platforms.
- Analysis of specific nanomaterial formulations like liposomes and polymeric nanoparticles.
Main Results:
- Nanomaterials enhance drug delivery, reduce off-target effects, and enable combination therapies for lung cancer.
- Liposomal and polymeric nanoparticles demonstrate potential in overcoming biological barriers and improving treatment outcomes.
- Key strategies include stimuli-responsive designs and active targeting for enhanced efficacy.
Conclusions:
- Nanomedicine presents a transformative approach to lung cancer therapy, improving drug delivery and reducing toxicity.
- Challenges such as tumor penetration, immunogenicity, and manufacturing scalability need to be addressed for clinical translation.
- Interdisciplinary collaboration and innovative design are crucial for advancing nanomedicine in lung cancer treatment.
